期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (5)
Purpose of Review The purpose of this review is to explore the prevalence and risk factors for a malignant phenotype in mitral valve prolapse (MVP) ch......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (12)
Purpose of review Beta blockers are currently widely used for the treatment of arrhythmias, due to their beneficial properties of sympathetic tone dec......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (9)
Purpose of Review Heart failure and cancer share common risk factors. We sought to describe outcomes of advanced heart failure therapies in the cardio......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (12)
Purpose of review Heart failure (HF) hospitalizations are common, costly, associated with poor outcomes and potentially avoidable. Reducing HF hospita......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (3)
Purpose of Review Implantable cardioverter-defibrillator (ICD) shocks, whether appropriate or inappropriate, are associated with significant morbidity......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (12)
Purpose of review To describe the role of iron deficiency in both heart failure and pulmonary hypertension. Recent findings To role of iron deficiency......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (1)
Purpose Transcatheter aortic valve implantation (TAVI) has grown in popularity as an alternative to surgical aortic valve replacement (SAVR) for the m......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (6)
Purpose of Review A significant proportion of patients infected by the severe acute respiratory syndrome-coronavirus (SARS-CoV2) (COVID-19) also have ......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (7)
Purpose of review Implantable cardiac defibrillators have been utilised in ischemic cardiomyopathy patients, in a primary prevention capacity since 19......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (6)
Purpose of review Aortic stenosis (AS) is associated with high morbidity and mortality. Despite the growing prevalence of AS among an aging and increa......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (11)
Purpose of Review To evaluate the evidence supporting the use of exercise training as a treatment strategy to reduce risk of cardiovascular disease (C......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (8)
Purpose of review The COVID-19 pandemic has disrupted healthcare and has disproportionately affected the marginalized populations. Patients with cance......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (4)
Purpose of review Percutaneous left atrial appendage closure (LAAC) with WATCHMAN (Boston Scientific Inc.) has emerged as a viable non-pharmacological......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (10)
Purpose of Review The goal of this review is to provide the reader with an overview of symptomatic carotid stenosis and the approach to medical manage......
期刊： CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2022; 24 (2)
Purpose of review To provide a taxonomy for grouping diagnostic maneuvers during an electrophysiology study for supraventricular tachycardia into mech......
